Insulet (PODD) Upgraded to Strong Buy: Here's What You Should KnowZacks Investment Research • 11/10/25
Insulet Rises As Broad Omnipod Growth Stokes Beat-And-Raise QuarterInvestors Business Daily • 11/06/25
Ahead of Insulet (PODD) Q3 Earnings: Get Ready With Wall Street Estimates for Key MetricsZacks Investment Research • 11/04/25
Insulet (PODD) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 10/30/25
Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness MonthBusiness Wire • 10/30/25
Insulet Announces Appointment of Robert L. Huffines to its Board of DirectorsBusiness Wire • 10/23/25
Insulet Stock Surges 37.4% in 12 months: What's Driving the Rally?Zacks Investment Research • 09/26/25
These 15 stocks have beaten the S&P 500 this year — while getting cheaper in the processMarket Watch • 09/22/25
Insulet Corporation (PODD) Presents At Baird Global Healthcare Conference 2025 TranscriptSeeking Alpha • 09/09/25
Insulet Corporation (PODD) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 TranscriptSeeking Alpha • 09/04/25
Omnipod Maker Insulet Is In A Buy Zone As Its Market Expands To MillionsInvestors Business Daily • 08/29/25